PEDIATRICS Vol. 101 No. 5 May 1998, pp. 926-928
EXPERIENCE AND REASON:
Minocycline-induced Lupus in Adolescents
| The first 20% of the full text of this article appears below. |
 |
INTRODUCTION |
|---|
Minocycline is a semisynthetic tetracycline antibiotic with a prolonged half-life. Its chief indications are the treatment of Rickettsia, Mycoplasma, Chlamydia, and Brucella infections, but it is also commonly used for the treatment of acne in doses of 50 to 100 mg daily.1 Its side effects include skin and tooth discoloration, gastrointestinal intolerance, hemolytic anemia, elevations in blood urea nitrogen, pneumonitis, and hepatitis. Also, a minocycline-related lupus-like syndrome presenting with findings including fever, arthritis, and rash has been reported mostly in young adults.2-7 We report five adolescent girls who developed lupus-like syndromes during treatment with minocycline for acne, so as to promote physician awareness, as differentiating this syndrome from genuine systemic lupus erythematosus (SLE) has important therapeutic and prognostic implications.
| |
METHODS AND PATIENTS |
|---|
The patients were girls ranging in age from 14 to 17 years who were referred to the pediatric rheumatology clinic at the Floating Hospital for Children by their primary pediatricians because of suspected lupus or other rheumatic disease. Drug exposures were sought during routine history taking. Serologic tests were performed at the New England Medical Center using standard methods. Antihistone antibodies were assayed at a commercial laboratory (Smithkline Beecham, Framingham, MA).
Case Report
Patient 2, a 16-year-old girl, presented with 2 weeks of daily
fevers, fatigue, and diffuse arthralgias beginning 12 hours after
receiving hepatitis B and diphteria-tetanus vaccines. She had been
taking minocycline
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Schiff and L. L. Barton Minocycline for Acne and Autoimmune Disease AAP Grand Rounds, December 1, 2008; 20(6): 61 - 62. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Brundula, N. B. Rewcastle, L. M. Metz, C. C. Bernard, and V. W. Yong Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis Brain, June 1, 2002; 125(6): 1297 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Lawson, N. Amos, D. Bulgen, and B. D. Williams Minocycline-induced lupus: clinical features and response to rechallenge Rheumatology, March 1, 2001; 40(3): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Corona Minocycline in Acne Is Still an Issue Arch Dermatol, September 1, 2000; 136(9): 1143 - 1145. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tournigand, T. Genereau, M. Prudent, M.-C. Diemert, S. Herson, and O. Chosidow Minocycline-induced clinical and biological lupus-like disease Lupus, November 1, 1999; 8(9): 773 - 774. [Abstract] [PDF]
|
|
|
|
 |
|
 C. S. Christodoulou, P. Emmanuel, R. A. Ray, R. A. Good, B. M. Schnapf, and G. D. Cawkwell Respiratory Distress Due to Minocycline-Induced Pulmonary Lupus Chest, May 1, 1999; 115(5): 1471 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Teitelbaum, A. R. Perez-Atayde, M. Cohen, A. Bousvaros, and M. M. Jonas Minocycline-Related Autoimmune Hepatitis: Case Series and Literature Review Arch Pediatr Adolesc Med, November 1, 1998; 152(11): 1132 - 1136. [Abstract] [Full Text] [PDF]
|
|
